Skip to content
Aton
EN
FR
EN
FR
Home
About Us
Our Strategy
Our Platforms
Open menu
Our Platforms
Preclinical & Clinical Services
Monoclonal Antibodies Production
Laboratory Equipment Production
Human Tissue Provision
Insights & News
Contact Us
Investors
Newsletter Signup
Half-year results 2022
Agreement on sale of shares by DMS group
Crohn’s disease treatment by Inoviem Scientific
Stemcis obtains FDA clearance
Stemcis distribution agreement in the United States
Myfill arthrot-therapy protocol training by Stemcis
Annual results 2021
Stemcis and the Macrofill Vacuum
Appointment of new General Manager
Stemcis and Macrofill Vacuum
